Related references
Note: Only part of the references are listed.A phase I study of Triapine® in combination with doxorubicin in patients with advanced solid tumors
William R. Schelman et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
A Phase I study of the novel ribonucleotide reductase inhibitor 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine((R))) in combination with the nucleoside analog fludarabine for patients with refractory acute leukemias and aggressive myeloproliferative disorders
Judith E. Karp et al.
LEUKEMIA RESEARCH (2008)
Synthesis, characterization, crystal structures, in vitro and in vivo antitumor activity of palladium(II) and zinc(II) complexes with 2-formyl and 2-acetyl pyridine N(4)-1-(2-pyridyl)-piperazinyl thiosemicarbazone
Dimitra Kovala-Demertzi et al.
POLYHEDRON (2008)
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
Brigette Ma et al.
INVESTIGATIONAL NEW DRUGS (2008)
A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret Hospital Phase II consortium
M. J. Mackenzie et al.
INVESTIGATIONAL NEW DRUGS (2007)
Phase II study of triapinea® in patients with metastatic renal cell carcinoma:: A trial of the national cancer institute of canada clinical trials group (NCIC IND.161)
Jennifer J. Knox et al.
INVESTIGATIONAL NEW DRUGS (2007)
Functionalized bis(thiosemicarbazonato) complexes of zinc and copper: Synthetic platforms toward site-specific radiopharmaceuticals
Jason P. Holland et al.
INORGANIC CHEMISTRY (2007)
Chelators at the cancer coalface: Desferrioxamine to triapine and beyond
Yu Yu et al.
CLINICAL CANCER RESEARCH (2006)
p-dimethylaminobenzaldehyde thiosemicarbazone:: A simple novel selective and sensitive fluorescent sensor for mercury(II)
Y Yu et al.
TALANTA (2006)
A ferrous-Triapine complex mediates formation of reactive oxygen species chat inactivate human ribonucleotide reductase
JM Shao et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Zinc(II) complexes derived from pyridine-2-carbaldehyde thiosemicarbazone and (1E)-1-pyridin-2-ylethan-1-one thiosemicarbazone. Synthesis, crystal structures and antiproliferative activity of zinc(II) complexes
Dimitra Kovala-Demertzi et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2006)
Fluorescence studies of the intra-cellular distribution of zinc bis(thiosemicarbazone) complexes in human cancer cells
AR Cowley et al.
CHEMICAL COMMUNICATIONS (2005)
Share Paper
